AHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM
TUESDAY, Nov. 8, 2022 (HealthDay News) — For patients with type 2 diabetes, hypertriglyceridemia, and low high-density lipoprotein cholesterol levels, the incidence of cardiovascular events is not lower with pemafibrate versus placebo, according to a…
Learn More6 ‘Heart-Healthy’ Supplements Flop in Cholesterol Study
MONDAY, Nov. 7, 2022 (HealthDay News) — Folks taking dietary supplements intended to help their heart health are just wasting their money, a new clinical trial suggests.Six supplements widely promoted as heart-healthy — fish oil, cinnamon, garlic, tu…
Learn MoreExperimental Pill May Be New Way to Control Cholesterol
MONDAY, Nov. 7, 2022 (HealthDay News) — Millions of people take daily medication to lower their cholesterol levels and prevent heart attacks, but there hasn’t been a drug that targets a dangerous type of cholesterol in the blood known as lipoprotein(…
Learn MoreIs Surgery Always Necessary for Folks With Chronic Angina?
MONDAY, Nov. 7, 2022 (HealthDay News) — Folks suffering chest pain from clogged arteries appear to have some true flexibility in choosing the medical care that’s right for them, researchers report.That’s because their overall risk of death is about t…
Learn MoreLipid Ratios Linked to Benign Prostatic Hyperplasia Risk
FRIDAY, Nov. 4, 2022 (HealthDay News) — In the Chinese population, the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio and the total cholesterol (TC)/HDL-C ratio are associated with an increased risk for benign prostatic hyperpl…
Learn MoreComorbidity Burden Higher in Generalized Pustular Psoriasis
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — Patients with generalized pustular psoriasis (GPP) have increased comorbidity compared with the general population and with patients with psoriasis vulgaris (PV), according to a study published online Oct. …
Learn MorePaxlovid, un medicamento para la COVID, podría interactuar con medicamentos cardiacos
JUEVES, 13 de octubre de 2022 (HealthDay News) — Paxlovid, un antiviral para la COVID-19, ha sido un punto de inflexión en la pandemia global, al proteger a los pacientes con un riesgo alto de los efectos más devastadores del coronavirus.Pero el mism…
Learn MoreCOVID Drug Paxlovid Might Interact With Heart Meds
THURSDAY, Oct. 13, 2022 (HealthDay News) — The COVID-19 antiviral Paxlovid has been a game-changer in the global pandemic, shielding high-risk patients from the coronavirus’ most devastating effects.But Paxlovid can itself pose a risk for people taki…
Learn MoreBiggest Study Yet Finds No Link Between Statins, Muscle Aches
MONDAY, Aug. 29, 2022 (HealthDay News) — Cholesterol-lowering statins are proven lifesavers, but they’ve also gained a reputation for causing muscle aches and pains in a good number of patients.That reputation is undeserved, according to a new large-…
Learn MoreGuidance Developed for Addressing Use of Nonstatin Therapies
MONDAY, Aug. 29, 2022 (HealthDay News) — Several new nonstatin agents have low-density lipoprotein cholesterol-lowering efficacy and can be considered for patients at risk for atherosclerotic cardiovascular disease (ASCVD), according to an expert c…
Learn More